Endocrinology News

PHILADELPHIA — Older adults with end-stage kidney disease undergoing bariatric surgery may be more likely to achieve kidney transplant, according to data presented at the American Transplant Congress.

Olezarsen, an antisense oligonucleotide targeting mRNA for apolipoprotein C-III, lowered triglycerides at 6 months for patients with familial chylomicronemia syndrome without excessive adverse events, researchers reported.

Olezarsen, an antisense oligonucleotide targeting mRNA for apolipoprotein C-III, lowered triglycerides at 6 months for patients with familial chylomicronemia syndrome without excessive adverse events, researchers reported.

Multidisciplinary experts from across cardiometabolic subspecialties will gather again to showcase the latest clinical research at the Heart in Diabetes CME Conference.

BOSTON —In this video exclusive, Richard J. Auchus, MD, PhD, describes a possible new treatment paradigm for congenital adrenal hyperplasia with crinecerfont, an investigational drug granted a breakthrough designation in December.

BOSTON — The majority of people with acromegaly receiving oral octreotide achieve a biochemical response, regardless of their baseline insulin-like growth factor I level, according to data from a post hoc analysis.

A continuous glucose monitoring system has the capability to connect directly with the Apple Watch for people with diabetes, according to a press release from Dexcom.

In this Healio video exclusive, Michael S. Garshick, MD, MS, discusses the role of inflammation in heart disease and how it has become a treatment target.

Regardless of socioeconomic status, menopause symptom severity was associated with race and ethnicity, highlighting differences in symptom experiences, according to study results published in Menopause.

BOSTON — In this video exclusive, Andrea Dunaif, MD, discusses some of the latest research on polycystic ovary syndrome featured at the ENDO 2024.